Finch Therapeutics Group Inc (NASDAQ: FNCH) is a clinical-stage biotherapeutics company developing microbiome-based therapies. The filing excerpts provided do not contain sufficient operational or financial detail to describe the revenue model, product pipeline status, competitive position, geographic footprint, or capital structure with the specificity required for a grounded description. Based solely on the available 10-K excerpt filed 2024-03-25 (accession 000095017024035952), no revenue figures, product names, clinical stage data, customer counts, or competitor names are disclosed in the supplied text. A complete description cannot be constructed without unsupported inference.

Source: SEC 10-K, filed 2024-03-25

Industry: Biological Products, (No Diagnostic Substances) Peers: Assembly Biosciences Inc aTyr Pharma Inc GELESIS HOLDINGS, INC. Surrozen Inc Fortress Biotech Inc Cue Biopharma, Inc. PDS Biotechnology Corp Palvella Therapeutics Inc Xilio Therapeutics Inc